keyword
https://read.qxmd.com/read/38722206/prophylactic-antibiotics-delivered-via-the-respiratory-tract-to-reduce-ventilator-associated-pneumonia-a-systematic-review-network-meta-analysis-and-trial-sequential-analysis-of-randomized-controlled-trials
#1
JOURNAL ARTICLE
Jie Li, Shan Lyu, Jian Luo, Ping Liu, Fai A Albuainain, Omar A Alamoudi, Violaine Rochette, Stephan Ehrmann
OBJECTIVES: To assess the effects of antibiotics delivered via the respiratory tract in preventing ventilator-associated pneumonia (VAP). DATA SOURCES: We searched PubMed, Scopus, the Cochrane Library, and ClinicalTrials.gov for studies published in English up to October 25, 2023. STUDY SELECTION: Adult patients with mechanical ventilation of over 48 h and receiving inhaled or instilled antibiotics (with control group) to prevent VAP were included...
May 9, 2024: Critical Care Medicine
https://read.qxmd.com/read/38719226/comparison-of-forward-leaning-and-fowler-position-effects-on-vital-signs-pain-and-anxiety-scores-in-children-with-asthma-exacerbations
#2
JOURNAL ARTICLE
Gamze Kaş Alay, Suzan Yıldız
BACKGROUND: It is essential to relieve bronchospasm or specific asthma symptoms by administering immediate inhaler treatment during an asthma exacerbation. The present study compared the effect of Fowler position and forward-leaning positions during nebulization on heart rate, SpO2 , breathing frequency, pain, and anxiety levels in children experiencing asthma exacerbations. METHODS: The data originated from a randomized trial that compared 86 participants (study group n = 43, control group n = 43) who presented to the pediatric emergency department with asthma exacerbations between October 2019-February 2020...
May 7, 2024: Respiratory Care
https://read.qxmd.com/read/38713181/meta-analysis-of-the-efficacy-of-montelukast-sodium-combined-with-nebulized-inhalation-in-the-treatment-of-childhood-asthma
#3
JOURNAL ARTICLE
Qiuhong He, Quandong Xu
No abstract text is available yet for this article.
May 7, 2024: Minerva surgery
https://read.qxmd.com/read/38713036/-the-role-of-spectral-analysis-of-cough-sounds-in-the-diagnosis-of-covid-19
#4
JOURNAL ARTICLE
A V Budnevsky, E S Ovsyannikov, S N Avdeev, O N Choporov, S N Feigelman, A V Maksimov
AIM: To evaluate the possibility of using spectral analysis of cough sounds in the diagnosis of a new coronavirus infection COVID-19. MATERIALS AND METHODS: Spectral toussophonobarography was performed in 218 patients with COVID-19 [48.56% men, 51.44% women, average age 40.2 (32.4; 51.0)], in 60 healthy individuals [50% men, 50% women, average age 41.7 (32.2; 53.0)] with induced cough (by inhalation of citric acid solution at a concentration of 20 g/l through a nebulizer)...
April 16, 2024: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/38698565/albuterol-budesonide-fixed-dose-combination-rescue-inhaler-for-asthma-a-plain-language-summary-of-the-mandala-study
#5
REVIEW
Alberto Papi, Bradley E Chipps, Richard Beasley, Reynold A Panettieri, Elliot Israel, Mark Cooper, Lynn Dunsire, Allison Jeynes-Ellis, Robert Rees, Frank C Albers, Christy Cappelletti
What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol-budesonide , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38698403/efficacy-of-adjunctive-inhaled-colistin-and-tobramycin-for-ventilator-associated-pneumonia-systematic-review-and-meta-analysis
#6
JOURNAL ARTICLE
Jefferson Antonio Buendía, Diana Guerrero Patiño, Andrés Felipe Zuluaga Salazar
INTRODUCTION: Ventilator-associated pneumonia (VAP) presents a significant challenge in intensive care units (ICUs). Nebulized antibiotics, particularly colistin and tobramycin, are commonly prescribed for VAP patients. However, the appropriateness of using inhaled antibiotics for VAP remains a subject of debate among experts. This study aims to provide updated insights on the efficacy of adjunctive inhaled colistin and tobramycin through a comprehensive systematic review and meta-analysis...
May 2, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38688545/pulmonologist-education-of-the-teach-to-goal-inhaler-technique-for-those-with-asthma-and-copd
#7
JOURNAL ARTICLE
Vaishali Mehta, Najia Sayedy, Joshua Fogel, Eric Lam, Pratap Upadrista, Bruno Okoro, Hira Tahir, Jagadish Akella
BACKGROUND: Inhaler education for patients with asthma and patients with COPD is typically provided by non-pulmonologists. We studied inhaler education by pulmonologists to determine changes in clinical outcomes and inhaler use. METHODS: This was a retrospective study of 296 subjects diagnosed with asthma, COPD, or both that evaluated use of inhaler technique education and its impact on (1) inhaler/dosage change consisting of dosage change in the same class of inhaler and/or change in number of inhalers, (2) forced expiratory volume in one second/forced vital capacity (FEV1 /FVC%), (3) disease symptom control, (4) out-patient visits, (5) urgent care visits (6) emergency department visits, and (7) hospital admissions...
April 30, 2024: Respiratory Care
https://read.qxmd.com/read/38687321/safety-and-efficacy-of-2-5%C3%A2-mg-and-1-25%C3%A2-mg-nebulized-salbutamol-compared-with-placebo-on-transient-tachypnea-of-the-newborns-a-triple-blind-phase-ii-iii-parallel-randomized-controlled-trial
#8
JOURNAL ARTICLE
Farhad Abolhasan Choobdar, Zahra Vahedi, Ali Mazouri, Mohammad Torkaman, Nastaran Khosravi, Nasrin Khalesi, Zahra Soltani, Arash Mohazzab, Rezvan Ashkanipour
Background: To evaluate the safety and efficacy of 2.5 and 1.25 mg nebulized salbutamol on Transient Tachypnea of the Newborn (TTN) compared with placebo. Methods: We conducted a triple-blind, phase II/III parallel randomized controlled trial in two university-affiliated hospitals with neonatal intensive care units. Newborns with a confirmed diagnosis of TTN, with gestational age >35 weeks and gestational weight >2 kg were included. Cases of asphyxia, meconium aspiration syndrome, and persistent pulmonary hypertension were excluded...
May 2, 2024: Journal of Aerosol Medicine and Pulmonary Drug Delivery
https://read.qxmd.com/read/38687314/clinical-usefulness-of-nebulized-dexmedetomidine-for-conscious-sedation-in-daycare-flexible-bronchoscopy-in-southern-india
#9
RANDOMIZED CONTROLLED TRIAL
Thomas Antony, K Vishak Acharya, Preetam Rajgopal Acharya, Himani Kotian, Sindhu Kamath
BACKGROUND: Sedative agents used in bronchoscopy require trained personnel to administer and monitor the patient. This increases the procedure cost, duration, and inpatient stay. Inhalational administration of sedative agents can be a practical solution to the issue. Dexmedetomidine in the inhalational form could give results similar to the intravenous form without significant adverse events. MATERIALS AND METHODS: The study is prospective, randomized, and double-blinded study...
March 1, 2024: Indian Journal of Pharmacology
https://read.qxmd.com/read/38683652/nebulizers
#10
JOURNAL ARTICLE
James B Fink, Kevin W Stapleton
Nebulizers generate aerosols from liquid-based solutions and suspensions. Nebulizers are particularly well suited to delivering larger doses of medication than is practical with inhalers and are used with a broad range of liquid formulations. When the same drug is available in liquid or inhaler form, nebulizers are applicable for use with patients who will not or cannot reliably use a pressurized metered-dosed inhaler (pMDI) or dry powder inhaler (DPI) due to poor lung function, hand-breath coordination, cognitive abilities (e...
April 29, 2024: Journal of Aerosol Medicine and Pulmonary Drug Delivery
https://read.qxmd.com/read/38683138/treatment-with-inhaled-aerosolised-ethanol-reduces-viral-load-and-potentiates-macrophage-responses-in-an-established-influenza-mouse-model
#11
JOURNAL ARTICLE
David G Hancock, Luke Berry, Naomi M Scott, Kyle T Mincham, William Ditcham, Alexander N Larcombe, Barry Clements
AIM: Treatment options for viral lung infections are currently limited. We aimed to explore the safety and efficacy of inhaled ethanol in an influenza-infection mouse model. MATERIALS AND METHODS: In a safety and tolerability experiment, 80 healthy female BALB/c mice (20 per group) were exposed to nebulized saline (control) or three concentrations of ethanol (40/60/80% ethanol v/v in water) for 3x30-minute periods, with a two-hour break between exposures. In a separate subsequent experiment, 40 Female BALB/c mice were nasally inoculated with 104...
2024: Experimental Lung Research
https://read.qxmd.com/read/38673555/validation-of-an-inhaled-therapy-beliefs-questionnaire-in-patients-with-chronic-obstructive-pulmonary-disease
#12
JOURNAL ARTICLE
Francisca Muñoz-Cobos, Virginia P Aguiar-Leiva, Carmen Argüello-Suárez, Paula Colacicchi, Luis Antonio Calleja-Cartón, Francisca Leiva-Fernández
Background : To carry out a validation questionnaire that assesses beliefs about inhaled treatments in patients with chronic obstructive pulmonary disease (COPD), as knowing patients' beliefs could help to improve medication adherence and health outcomes. Methods : We evaluated data from 260 COPD patients from electronic medical record databases from five primary healthcare centers, in a descriptive, cross-sectional study with a sample size calculated for a 10-item questionnaire, with an estimated Cronbach's alpha of 0...
April 15, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38670294/preparation-and-evaluation-of-inhalable-s-allylmercapto-n-acetylcysteine-and-nintedanib-co-loaded-liposomes-for-pulmonary-fibrosis
#13
JOURNAL ARTICLE
Qinxiu Zhang, Genju Li, Guozhi Zhao, Chongzheng Yan, Huaiyou Lv, Yaqing Fu, Yuhan Li, Zhongxi Zhao
Orally marketed products nintedanib (NDNB) and pirfenidone (PFD) for pulmonary fibrosis (PF) are administered in high doses and have been shown to have serious toxic and side effects. NDNB can cause the elevation of galectin-3, which activates the NF-κB signaling pathway and causes the inflammatory response. S-allylmercapto-N-acetylcysteine (ASSNAC) can alleviate the inflammation response by inhibiting the TLR-4/NF-κB signaling pathway. Therefore, we designed and prepared inhalable ASSNAC and NDNB co-loaded liposomes for the treatment of pulmonary fibrosis...
April 24, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38657716/investigating-the-effectiveness-of-liposome-bacteriophage-nanocomplex-in-killing-staphylococcus-aureus-using-epithelial-cell-coculture-models
#14
JOURNAL ARTICLE
Jiaqi Li, Huangliang Zheng, Sharon Shui Yee Leung
Host cell invasion with strong antibiotics evading is a major feature of respiratory Staphylococcus aureus infections with severe recurrence. Bacteriophage (phage) therapy and design of liposomal phage to target intracellular pathogens have been described recently. The practicality for pulmonary delivery of liposomal phage, and how formulation compositions affecting the aerosolization and intracellular bacterial killing remain unexplored. In the present study, three commonly used phospholipids (SPC, EPC, and HSPC) were selected to investigate their ability for phage K nebulization and intracellular therapy in the form of liposome-phage nanocomplexes...
April 22, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38632501/phase-i-ii-clinical-trial-of-efficacy-and-safety-of-egcg-oxygen-nebulization-inhalation-in-the-treatment-of-covid-19-pneumonia-patients-with-cancer
#15
JOURNAL ARTICLE
Xiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, Guangjian Yang, Xianguang Zhao, Kaikai Zhao, Liyang Jiang, Xiaolin Li, Hong Zhao, Xin Wang, Yuanyuan Yan, Ligang Xing, Jinming Yu, Xiangjiao Meng, Hanxi Zhao
BACKGROUND: The antiviral drug Nirmatrelvir was found to be a key drug in controlling the progression of pneumonia during the infectious phase of COVID-19. However, there are very few options for effective treatment for cancer patients who have viral pneumonia. Glucocorticoids is one of the effective means to control pneumonia, but there are many adverse events. EGCG is a natural low toxic compound with anti-inflammatory function. Thus, this study was designed to investigate the safety and efficacy of epigallocatechin-3-gallate (EGCG) aerosol to control COVID-19 pneumonia in cancer populations...
April 17, 2024: BMC Cancer
https://read.qxmd.com/read/38622443/interchanging-reusable-and-disposable-nebulizers-used-with-home-based-compressors-may-result-in-inconsistent-dosing-a-laboratory-investigation-with-device-combinations-supplied-to-the-us-healthcare-environment
#16
JOURNAL ARTICLE
Judy Schloss, Dominic P Coppolo, Jason A Suggett, Mark W Nagel, Jolyon P Mitchell
INTRODUCTION: Reusable nebulizer-compressor combinations deliver inhaled medications for patients with chronic lung diseases. On hospital discharge, the patient may take home the disposable nebulizer that was packaged and combine it with their home compressor. Though this practice may reduce waste, it can increase variability in medication delivery. Our study compared several reusable and disposable nebulizers packaged with compressor kits used in the US. We included a common disposable hospital nebulizer that may not be supplied with popular home kits but may be brought home after a hospitalization or emergency department visit...
April 15, 2024: Pulmonary Therapy
https://read.qxmd.com/read/38621181/microfluidic-platform-enables-shearless-aerosolization-of-lipid-nanoparticles-for-mrna-inhalation
#17
JOURNAL ARTICLE
Jeonghwan Kim, Antony Jozić, Elissa Bloom, Brian Jones, Michael Marra, Namratha Turuvekere Vittala Murthy, Yulia Eygeris, Gaurav Sahay
Leveraging the extensive surface area of the lungs for gene therapy, the inhalation route offers distinct advantages for delivery. Clinical nebulizers that employ vibrating mesh technology are the standard choice for converting liquid medicines into aerosols. However, they have limitations when it comes to delivering mRNA through inhalation, including severe damage to nanoparticles due to shearing forces. Here, we introduce a microfluidic aerosolization platform (MAP) that preserves the structural and physicochemical integrity of lipid nanoparticles, enabling safe and efficient delivery of mRNA to the respiratory system...
April 15, 2024: ACS Nano
https://read.qxmd.com/read/38613545/orally-inhaled-flecainide-for-conversion-of-atrial-fibrillation-to-sinus-rhythm-instant-phase-2-trial
#18
JOURNAL ARTICLE
Jeremy N Ruskin, A John Camm, Christopher Dufton, Anderson C Woite-Silva, Ype Tuininga, Erik Badings, Jonas S S G De Jong, Thomas Oosterhof, Ismail Aksoy, Aaf F M Kuijper, Isabelle C Van Gelder, Vincent van Dijk, Dieter Nuyens, Dirk Schellings, Mark Young Lee, Peter R Kowey, Harry J G M Crijns, Jean Maupas, Luiz Belardinelli
BACKGROUND: INSTANT (INhalation of flecainide to convert recent-onset SympTomatic Atrial fibrillatioN to sinus rhyThm) was a multicenter, open-label, single-arm study of flecainide acetate oral inhalation solution (FlecIH) for acute conversion of recent-onset (≤48 hours) symptomatic atrial fibrillation (AF) to sinus rhythm. OBJECTIVES: This study investigated the efficacy and safety in 98 patients receiving a single dose of FlecIH delivered via oral inhalation...
March 26, 2024: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/38605938/tobramycin-systemic-absorption-in-lung-transplant-recipients-treated-with-inhaled-tobramycin-a-cohort-study
#19
JOURNAL ARTICLE
Abiu Sempere, Ibai Los-Arcos, Judith Sacanell, Cristina Berastegui, David Campany-Herrero, Jaume Vima, María Teresa Martín-Gómez, Leire Sánchez, Daniel Martínez-González, Carles Bravo, Oscar Len, Joan Gavaldà
Inhaled tobramycin treatment has been associated with nephrotoxicity in some case reports, but limited data are available about serum levels and its possible systemic absorption in lung transplant recipients (LTR). We conducted a single-center, observational and retrospective study of all adult (>18 years old) LTR treated with inhaled tobramycin for at least 3 days between June 2019 and February 2022. Trough serum levels were collected and >2 μg/mL was considered a high drug level...
2024: Transplant International
https://read.qxmd.com/read/38604048/comparative-evaluation-of-nebulized-versus-intravenous-dexmedetomidine-on-intubating-conditions-during-awake-fiberoptic-nasotracheal-intubation
#20
JOURNAL ARTICLE
Anju Romina Bhalotra, Mona Arya, Rahil Singh, Shweta Dhiman
BACKGROUND: There is a search for an ideal agent to facilitate awake fiberoptic intubation (AFOI). Dexmedetomidine is a selective α2 agonist which can be administered through intravenous, intramuscular, buccal, intranasal & inhalational routes. It provides good intubation conditions without oxygen desaturation but may cause hypotension and bradycardia when administered intravenously. Hence, alternative routes of administering dexmedetomidine which may improve its safety profile are worth exploring...
April 10, 2024: Journal of Clinical Anesthesia
keyword
keyword
9189
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.